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Health Policy Forum:  Update on Medicare Disease 
Management Demonstration Projects 
___________________________________________________________________ 
 
The Department of Health Policy opened its 2004 Forum series on January 14th with 
a presentation by Stuart Guterman of the Centers for Medicare and Medicaid 
Services (CMS).  Guterman, Director of the Office of Research, Development and 
Information, addressed CMS’s efforts to bring Medicare into the 21st century by 
using disease management to both improve beneficiary care and reduce costs. 
 
Beneficiaries with chronic conditions make up an increasing proportion of the 
Medicare population. According to Guterman, neither traditional fee-for-service 
Medicare nor Medicare+Choice is currently structured to adequately provide for these 
patients, who tend to receive fragmented care from multiple providers and multiple 
sites and often require repeated, costly hospitalizations. 
 
In order to identify innovative ways to improve the care of chronically ill 
beneficiaries, CMS has undertaken a series of demonstrations to test the value of 
disease management for Medicare beneficiaries. The objective of disease 
management programs is to combine adherence to evidence-based treatment 
guidelines with better coordination of care across providers.  CMS will evaluate the 
programs based on health outcomes, cost-effectiveness for Medicare, beneficiary and 
provider satisfaction, and other quality and outcomes measurers. 
 
Projects already underway include the Coordinated Care Demonstration, which is 
designed to provide disease management services to Medicare fee-for-services 
beneficiaries with certain complex chronic conditions, including congestive heart 
failure, heart, liver, and lung diseases, Alzheimer’s, cancer, and HIV/AIDS. Launched 
in 2002, the demonstration has been implemented at fifteen sites, including 
commercial disease management vendors, academic medical centers, and other 
provider-based programs. Thus far, said Guterman, the programs overall appear to 
be well received by both participating physicians and enrollees. 
 
Under the Demonstration for Severely Chronically Ill Medicare Beneficiaries, 
organizations are paid a monthly premium not only for coordinating patients’ care, 
but also for providing prescription drugs that Medicare currently does not cover. The 
three-year demonstration will assess whether disease management services 
combined with a drug benefit plan can improve the health outcomes of beneficiaries 
with advanced-stage congestive heart failure, diabetes, or coronary heart disease 
without increasing program costs. 
 
Additional projects to be implemented include a Capitated Disease Management 
Demonstration, which will pay organizations a capitated rate (a fixed amount each 
month per enrollee) to provide disease management services to Medicare 
beneficiaries with one or more chronic conditions.  The Care Management 
Performance Demonstration will focus on improvement in office systems and 
encourage physicians to adopt health information technology in order to manage 
chronically ill patients more efficiently and effectively. Also planned is a 
demonstration focusing on beneficiaries with end-stage renal disease, as well as a 
physician group practice demonstration, which will reward physicians for improving 
health outcomes. Through these demonstrations, CMS hopes to learn how well 
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disease management works and how best to provide these services to Medicare 
beneficiaries. 
 
More information on Medicare disease management demonstration projects can be 
found at www.cms.hhs.gov/researchers/demos. 
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